John McLauchlan

6.0k total citations · 1 hit paper
30 papers, 1.6k citations indexed

About

John McLauchlan is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, John McLauchlan has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 20 papers in Hepatology and 5 papers in Rheumatology. Recurrent topics in John McLauchlan's work include Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (11 papers) and Herpesvirus Infections and Treatments (10 papers). John McLauchlan is often cited by papers focused on Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (11 papers) and Herpesvirus Infections and Treatments (10 papers). John McLauchlan collaborates with scholars based in United Kingdom, Slovakia and United States. John McLauchlan's co-authors include Frazer J. Rixon, Daniel M. Jones, J. Barklie Clements, William L. Irving, Graham R. Foster, RM Hope, Kosh Agarwal, Michelle Cheung, William Gelson and Ben Hudson and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

John McLauchlan

30 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

2016 328 citations Graham R. Foster, William L. Irving et al. Journal of Hepatology profile →

Peers

John McLauchlan

EPIDE

HEPAT

IMMUN

GENET

Motoko Nagano‐Fujii Japan

Penelope Mavromara Greece

Volker Brass Germany

Michael J. McGarvey United Kingdom

Nicole Appel Germany

Christopher J. McCormick United Kingdom

William R. Addison Canada

Christophe Hourioux France

Agata Budkowska France

Jisu Li United States

Motoko Nagano‐Fujii Japan

John McLauchlan

799 ×0.6

EPIDE

846 ×0.8

HEPAT

314 ×1.4

218 ×1.2

IMMUN

74 ×0.5

GENET

Citations per year, relative to John McLauchlan John McLauchlan (= 1×) peers Motoko Nagano‐Fujii

Countries citing papers authored by John McLauchlan

Since Specialization

Citations

This map shows the geographic impact of John McLauchlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John McLauchlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John McLauchlan more than expected).

Fields of papers citing papers by John McLauchlan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John McLauchlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John McLauchlan. The network helps show where John McLauchlan may publish in the future.

Co-authorship network of co-authors of John McLauchlan

This figure shows the co-authorship network connecting the top 25 collaborators of John McLauchlan. A scholar is included among the top collaborators of John McLauchlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John McLauchlan. John McLauchlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Innes, Hamish, Alex J Walker, Jane I. Grove, et al.. (2022). Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis. Clinical and Translational Gastroenterology. 13(3). e00462–e00462. 2 indexed citations

Simmonds, Peter, Lize Cuypers, William L. Irving, et al.. (2020). Impact of virus subtype and host IFNL4 genotype on large-scale RNA structure formation in the genome of hepatitis C virus. RNA. 26(11). 1541–1556. 4 indexed citations

Wing, Peter A. C., Meleri Jones, Michelle Cheung, et al.. (2019). Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir. Gastroenterology. 157(3). 692–704.e9. 19 indexed citations

Bradshaw, Daniel, Jean L. Mbisa, Anna María Geretti, et al.. (2019). Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group. Journal of Infection. 79(6). 503–512. 13 indexed citations

Cheung, Michelle, Alex J Walker, Ben Hudson, et al.. (2016). Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis. Journal of Hepatology. 65(4). 741–747. 285 indexed citations

Foster, Graham R., William L. Irving, Michelle Cheung, et al.. (2016). Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis. Journal of Hepatology. 64(6). 1224–1231. 328 indexed citations breakdown →

Jones, Daniel M. & John McLauchlan. (2010). Hepatitis C Virus: Assembly and Release of Virus Particles. Journal of Biological Chemistry. 285(30). 22733–22739. 87 indexed citations

Jones, David M., Patricia Domingues, Paul Targett‐Adams, & John McLauchlan. (2010). Comparison of U2OS and Huh-7 cells for identifying host factors that affect hepatitis C virus RNA replication. Journal of General Virology. 91(9). 2238–2248. 30 indexed citations

Tang, Xi, Jessica Wagoner, Amina Negash, et al.. (2010). Functional Characterization of Core Genes from Patients with Acute Hepatitis C Virus Infection. The Journal of Infectious Diseases. 201(6). 912–922. 7 indexed citations

10.

Elliott, Ruth, et al.. (2009). Structural and molecular virology. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 5 indexed citations

11.

Targett‐Adams, Paul, Torsten Schaller, Robert E. Lanford, et al.. (2006). Signal Peptide Peptidase Cleavage of GB Virus B Core Protein Is Required for Productive Infection in Vivo. Journal of Biological Chemistry. 281(39). 29221–29227. 35 indexed citations

12.

Lila, Mohd Azmi Mohd, Hugh J. Field, Frazer J. Rixon, & John McLauchlan. (2002). Protective Immune Reponses Induced by Non-infectious L-particles of Equine Herpesvirus Type-1. The Journal of Microbiology. 40(1). 11–19. 4 indexed citations

13.

Hope, RM, Denis J. Murphy, & John McLauchlan. (2002). The Domains Required to Direct Core Proteins of Hepatitis C Virus and GB Virus-B to Lipid Droplets Share Common Features with Plant Oleosin Proteins. Journal of Biological Chemistry. 277(6). 4261–4270. 140 indexed citations

14.

Verjans, Georges M. G. M., John McLauchlan, Alex van der Kooi, et al.. (2000). Intraocular T Cells of Patients with Herpes Simplex Virus (HSV)–Induced Acute Retinal Necrosis Recognize HSV Tegument Proteins VP11/12 and VP13/14. The Journal of Infectious Diseases. 182(3). 923–927. 22 indexed citations

15.

McLauchlan, John. (1997). The abundance of the herpes simplex virus type 1 UL37 tegument protein in virus particles is closely controlled.. Journal of General Virology. 78(1). 189–194. 25 indexed citations

16.

Rixon, Frazer J., et al.. (1996). Overexpression of the Herpes Simplex Virus Type 1 Tegument Protein VP22 Increases Its Incorporation into Virus Particles. Virology. 220(1). 60–68. 50 indexed citations

17.

McLauchlan, John, et al.. (1994). Characterization of a Herpes Simplex Virus type 1 Deletion Variant (1703) Which Under-produces Vmw63 During Immediate Early Conditions of Infection. Journal of General Virology. 75(5). 1083–1089. 5 indexed citations

18.

Rixon, Frazer J., Clare Addison, & John McLauchlan. (1992). Assembly of enveloped tegument structures (L particles) can occur independently of virion maturation in herpes simplex virus type 1-infected cells. Journal of General Virology. 73(2). 277–284. 93 indexed citations

19.

McLauchlan, John & Frazer J. Rixon. (1992). Characterization of enveloped tegument structures (L particles) produced by alphaherpesviruses: integrity of the tegument does not depend on the presence of capsid or envelope. Journal of General Virology. 73(2). 269–276. 100 indexed citations

20.

McLauchlan, John & J. Barklie Clements. (1983). DNA sequence homology between two co-linear loci on the HSV genome which have different transforming abilities.. The EMBO Journal. 2(11). 1953–1961. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact